Main Article Content
The goal of this publication is to show the many uses for AMs in treating ocular surface disease and to provide a resource for their use in clinical practice.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of articles published in all DPG titles is retained by the author(s). The author(s) grants DPG the rights to publish the article and identify itself as the original publisher. The author grants DPG exclusive commercial rights to the article. The author grants any party the rights to use the article freely for non-commercial purposes provided that the original work is properly cited.
2. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45(Suppl. 2):S203–10.
3. Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul. Surf 2013;11:246–58.
4. Muri M, Moshirfar M. Birdsong O. 2018. Amniotic membrane extract and eye drops: a review of literature and clinical application, Clin Ophthalmol 2018;12:1105–12.